Predictive Oncology, Inc.(NASDAQ : POAI)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||0.29%||495.43||1.0%||$1075.59m|
|ISRG||Intuitive Surgical, Inc.||0.09%||906.23||2.3%||$456.46m|
|BDX||Becton, Dickinson & Co.||0.20%||240.70||1.0%||$384.58m|
|ALGN||Align Technology, Inc.||3.10%||624.59||6.3%||$313.62m|
|BSX||Boston Scientific Corp.||0.22%||43.89||1.0%||$277.94m|
|BAX||Baxter International, Inc.||0.58%||81.40||1.8%||$239.12m|
|EW||Edwards Lifesciences Corp.||-0.64%||104.09||0.4%||$239.10m|
|ZBH||Zimmer Biomet Holdings, Inc.||-0.35%||163.89||1.7%||$235.51m|
|A||Agilent Technologies, Inc.||-0.18%||146.97||1.6%||$235.19m|
|IDXX||IDEXX Laboratories, Inc.||-1.32%||607.73||3.8%||$213.16m|
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and Corporate. The Helomics segment includes clinical testing and contract research services that include the application of AI. The Skyline segment consists of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within corporate. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.